Busulfan
NDC 51817-170, busulfan, injection, from Pharmascience Inc..
- Product NDC
- 51817-170
- Status
- Listed
- Labeler
- Pharmascience Inc.
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207050
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51817-170 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUSULFAN6 mg/mL
Pharmacologic classes
Alkylating Activity [MoA]; Alkylating Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51817-170-01 | 51817017001 | 8 VIAL in 1 PACKAGE (51817-170-01) / 10 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/d0fe44f9-7747-4909-b927-3b24aa6e7e09
Use it
Look up 51817-170 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51817-170 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51817-170. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.